Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.

Viruses - 18 Jun 2021

Chaqroun Ahlam, Hartard Cédric, Schvoerer Evelyne

Abstract excerpt

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is genetically variable, allowing it to adapt to various hosts including humans. Indeed, SARS-CoV-2 has accumulated around two mutations per genome each month. The first relevant event in this context was the occurrence of the mutant D614G in the Spike gene. Moreover, several variants have emerged, including the well-characterized 20I/501Y.V1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Vaccines

Share to Mutation

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Source

Open in PubMed Open full text

Identifiers

PMID: 34207378
DOI: 10.3390/v13061171
PMCID: PMC8234553

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.PMID 34207378Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

A Comprehensive Account of SARS-CoV-2 Genome structure, Incurred mutations, Lineages and COVID-19 Vaccination ProgramSemantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacySemantic proximity Read ↗

SARS-CoV-2 variants: A double-edged sword?Semantic proximity Read ↗

Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.Semantic proximity Read ↗

The COVID-19 pandemic: viral variants and vaccine efficacySemantic proximity Read ↗

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read ↗

Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies.Semantic proximity Read ↗

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Semantic proximity Read ↗

Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategiesSemantic proximity Read ↗

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.